U.S. buys 10 million courses of Pfizer COVID-19 pill; CVS Health to close 900 stores as part of move toward health services; Novo Nordisk acquires RNAi pioneer Dicerna for $3.3 billion.
Tim Meadows stars in COVID vaccination campaign… about boners
Pfizer allows low-income countries to make and sell its COVID-19 pill cheaply; ViaCyte and CRISPR test type 1 diabetes cell therapy in new clinical trial; Moderna in talks to donate more vaccine doses to COVAX.
Five things for health marketers to know: Tuesday, November 16, 2021
U.S. COVID-19 cases increase again after post-Delta drop; Bristol Myers Squibb/Janssen blood thinner shows success in trial; Medidata co-founder Glen de Vries dies in plane crash.
Five things for health marketers to know: Monday, November 15, 2021
Texas ban on mask mandates in schools deemed a violation of federal law; Cortexyme plans to push forward on Alzheimer’s drug after failed trial; FDA recalls Allume at-home COVID tests.
Why isn’t Pfizer’s COVID-19 pill getting more play?
900,000 kids receive first Pfizer shot; Moderna/NIH dispute over vaccine patent heads to court; Inventprise receives $90 million in funding from Gates Foundation.